Belluscura PLC The Pulse: Healthcare Innovation Breakfast
01 Novembro 2021 - 4:00AM
RNS Non-Regulatory
TIDMBELL
Belluscura PLC
01 November 2021
Belluscura PLC
("Belluscura" or the "Company")
The Pulse: Healthcare Innovation Breakfast
CEO to present with London Stock Exchange Head of Primary
Markets at event in Dallas, Texas
Bob Rauker to discuss accessing alternative sources of capital
and his experience of listing a Company on the Alternative
Investment Market (AIM)
LONDON, U.K. AND PLANO, TX, U.S. (1 November 2021). Belluscura
plc (AIM: BELL), a leading medical device developer focused on
lightweight and portable oxygen enrichment technology , announces
that CEO Robert "Bob" Rauker will be presenting alongside Chris
Mayo, Head of Primary Markets (Americas), London Stock Exchange, at
The Pulse Healthcare Innovation Breakfast event taking place in
Dallas, Texas, USA, tomorrow.
The hybrid event, which is also supported by Department for
International Trade (DIT), is designed to highlight how US based
companies are taking advantage of lower cost execution and
maintenance of a UK listing. The speakers will also discuss the
high quality investor base for smaller companies and the ongoing
access to capital in London which has proven attractive to emerging
US growth companies. At the event, Bob Rauker will explain the
benefits of Belluscura's London IPO and take Q&A with Rachel
Carroll, President & Managing Partner of Edison Group, a global
independent equity research and investor relations firm.
Health Wildcatters, an organisation which provides investment
and key resources to support healthcare entrepreneurs, is hosting
the in-person event on Tuesday 2 November at 07:30am - 09:00am CT.
Those unable to be present are encouraged to attend a virtual
meeting to be held via Zoom between the hours of 08:00am - 09:00am
CT on the same day.
Interested parties can register for the event, below:
In Person: http://ow.ly/5cbi50Gnj8z
Virtual: http://ow.ly/QtXv50Gnj8x
A link to the Wildcatters website with the presentation
information: https://www.healthwildcatters.com/
The event is being recorded and will be available on the Health
WildCatters Youtube channel:
https://www.youtube.com/c/HealthWildcattersDallas/videos
Chris Mayo will briefly set the scene as to why many smaller US
emerging growth companies are looking to London Stock Exchange
after an introduction by Hubert Zajicek, MD, MBA and Geraldine
SCHOTT, PhD of the Department for International Trade (DIT).
About Reach announcements
Reach is an investor communication service aimed at assisting
listed and unlisted (including AIM quoted) companies to distribute
media only / non-regulatory news releases such as marketing
messages, corporate and product information into the public domain.
An RNS Regulatory announcement is required to be notified under the
AIM Rules for Companies.
For further information please contact:
Belluscura plc www.belluscura.com
Robert Rauker, Chief Executive via Walbrook PR
Officer
Anthony Dyer, Chief Financial
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Dowgate Capital Limited (Broker) Tel: +44 (0)20 3903 7715
James Serjeant / Nicholas Chambers
Walbrook PR Ltd (Media & Investor Tel: +44 (0)20 7933 8780 or belluscura@walbrookpr.com
Relations)
Paul McManus / Sam Allen Mob: +44 (0)7980 541 893 / +44 (0)7502
558 258
About Belluscura plc ( www.belluscura.com )
Belluscura is a UK medical device company focused on developing
oxygen enrichment technology spanning broad industries and
therapies. Our innovative oxygen technologies are designed with a
global purpose: to create improved health and economic outcomes for
the patients, healthcare providers and insurance organisations.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABUBDGDBDDGBC
(END) Dow Jones Newswires
November 01, 2021 03:00 ET (07:00 GMT)
Belluscura (LSE:BELL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Belluscura (LSE:BELL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024